The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
The activation of monocyte and T cell networks in patients with bipolar disorder
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
Brietzke, E., Stertz, L., Fernandes, B. S., Kauer-Sant’Anna, M., Mascarenhas, M., Escosteguy Vargas, A., Chies, J. A., & Kapczinski, F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.001 · Cited by 423
Padmos, R. C., Hillegers, M. H. J., Knijff, E. M., Vonk, R., Bouvy, A., Staal, F. J. T., de Ridder, D., Kupka, R. W., Nolen, W. A., & Drexhage, H. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.395 · Cited by 336
Self-citationDrexhage, R. C., Knijff, E. M., Padmos, R. C., Heul-Nieuwenhuijzen, L. V. D., Beumer, W., Versnel, M. A., & Drexhage, H. A. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.144 · Cited by 263
Self-citationCytokine levels in euthymic bipolar patients
Guloksuz, S., Aktas Cetin, E., Cetin, T., Deniz, G., Oral, E. T., & Nutt, D. J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.027 · Cited by 102
Research works printed but not linked: 25
- Bettelli, 2008, Induction and effector functions of T(H)17 cells, Nature, 453, 1051, 10.1038/nature07036 · DOI · Paper page
- Breunis, 2003, High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder, Biol. Psychiatry, 53, 157, 10.1016/S0006-3223(02)01452-X · DOI
- Crome, 2010, Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease, Clin. Exp. Immunol., 159, 109, 10.1111/j.1365-2249.2009.04037.x · DOI · Paper page
- Dejaco, 2006, Are regulatory T-cells linked with aging?, Exp. Gerontol., 41, 339, 10.1016/j.exger.2006.01.008 · DOI
- Drexhage, 2010, Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients, The international journal of neuropsychopharmacology/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 1
- Drzyzga, 2006, Cytokines in schizophrenia and the effects of antipsychotic drugs, Brain Behav. Immun., 20, 532, 10.1016/j.bbi.2006.02.002 · DOI · Paper page
- Knijff, 2006, Monocyte-derived dendritic cells in bipolar disorder, Biol. Psychiatry, 59, 317, 10.1016/j.biopsych.2005.06.041 · DOI
- Konsman, 2008, Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide, Europ. J Neurosci., 28, 2499, 10.1111/j.1460-9568.2008.06549.x · DOI
- Kupka, 2002, High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure, Biol. Psychiatry, 51, 305, 10.1016/S0006-3223(01)01217-3 · DOI · Paper page
- Liu, 2004, Immunologic variables in acute mania of bipolar disorder, J. Neuroimmunol., 150, 116, 10.1016/j.jneuroim.2004.01.006 · DOI
- Oomen, 1996, The prevalence of affective disorder and in particular of a rapid cycling of bipolar disorder in patients with abnormal thyroid function tests, Clin. Endocrinol. (Oxf), 45, 215, 10.1046/j.1365-2265.1996.d01-1558.x · DOI
- Ortiz-Dominguez, 2007, Immune variations in bipolar disorder: phasic differences, Bipolar Disorders, 9, 596, 10.1111/j.1399-5618.2007.00493.x · DOI · Paper page
- Padmos, 2004, A high prevalence of organ-specific autoimmunity in patients with bipolar disorder, Biol. Psychiatry, 56, 476, 10.1016/j.biopsych.2004.07.003 · DOI
- Padmos, 2009, Genetic and environmental influences on pro-inflammatory monocytes in bipolar disorder: a twin study, Arch. Gen. Psychiatry, 66, 957, 10.1001/archgenpsychiatry.2009.116 · DOI
- Pollmacher, 2000, Effects of antipsychotic drugs on cytokine networks, J. Psychiatr. Res., 34, 369, 10.1016/S0022-3956(00)00032-7 · DOI · Paper page
- Rybakowski, 2000, Antiviral and immunomodulatory effect of lithium, Pharmacopsychiatry, 33, 159
- Strieder, 2006, A reduced IL2R (CD25) expression level in first and second degree female relatives of autoimmune thyroid disease patients. A sign of a poor capability to preserve tolerance?, Autoimmunity, 39, 93, 10.1080/08916930500508092 · DOI
- Tiemessen, 2007, CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages, Proceedings of the National Academy of Sciences of the United States of America, 104, 19446, 10.1073/pnas.0706832104 · DOI · Paper page
- Tohmi, 2004, Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: implication in psychiatric disorders of developmental origin, Neurosci. Res., 50, 67, 10.1016/j.neures.2004.05.010 · DOI
- Tsai, 2001, Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania, J. Affect. Disord., 64, 185, 10.1016/S0165-0327(00)00252-4 · DOI
- van der Heul-Nieuwenhuijsen, 2010, An inflammatory gene-expression fingerprint in monocytes of autoimmune thyroid disease patients, J. Clin. Endocrinol. Metab., 95, 1962, 10.1210/jc.2009-1455 · DOI
- Vonk, 2007, Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder?, Biol. Psychiatry, 62, 135, 10.1016/j.biopsych.2006.08.041 · DOI
- Walker, 1997, The psychological and psychiatric effects of rIL-2 therapy: a controlled clinical trial, Psychooncology, 6, 290, 10.1002/(SICI)1099-1611(199712)6:4<290::AID-PON283>3.0.CO;2-G · DOI
- Wildin, 2002, Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome, J. Med. Genet., 39, 537, 10.1136/jmg.39.8.537 · DOI · Paper page
- Wing, 2010, Regulatory T cells exert checks and balances on self tolerance and autoimmunity, Nature Immunol., 11, 7, 10.1038/ni.1818 · DOI · Paper page
Cited by
Neuroinflammation and psychiatric illness
Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-43 · Cited by 733
Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies
Modabbernia, A., Taslimi, S., Brietzke, E., & Ashrafi, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.007 · Cited by 596
Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis
Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402
Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness
Berk, M., Dean, O., Drexhage, H., McNeil, J. J., Moylan, S., O'Neil, A., Davey, C. G., Sanna, L., & Maes, M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-74 · Cited by 391
Self-citationBeumer, W., Gibney, S. M., Drexhage, R. C., Pont-Lezica, L., Doorduin, J., Klein, H. C., Steiner, J., Connor, T. J., Harkin, A., Versnel, M. A., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212100 · Cited by 347
Immune targets for therapeutic development in depression: towards precision medicine
Drevets, W. C., Wittenberg, G. M., Bullmore, E. T., & Manji, H. K. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00368-1 · Cited by 348
Neuroinflammation in Bipolar Depression
Benedetti, F., Aggio, V., Pratesi, M. L., Greco, G., & Furlan, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00071 · Cited by 274
Stuart, M. J., & Baune, B. T. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.001 · Cited by 259
Cytokines in bipolar disorder: A systematic review and meta-analysis
Munkholm, K., Vinberg, M., & Vedel Kessing, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.010 · Cited by 256
Bipolar Disorder and Inflammation
Rosenblat, J. D., & McIntyre, R. S. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.09.006 · Cited by 186
Rosenblat, J. D., Brietzke, E., Mansur, R. B., Maruschak, N. A., Lee, Y., & McIntyre, R. S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.058 · Cited by 172
“Several studies have now shown pro-inflammatory cytokines to be elevated during periods of depression, mania and euthymia, indicative of a chronic, low-grade inflammatory state (Breunis et al., 2003; O’Brien et al., 2006; Brietzke et al., 2009a, 2009b; Drexhage et al., 2011; Modabbernia et al., 2013; Barbosa et al., 2…”
BackgroundNeuropathology of mood disorders: Do we see the stigmata of inflammation?
Mechawar, N., & Savitz, J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.212 · Cited by 165
Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder
Kalelioglu, T., Akkus, M., Karamustafalioglu, N., Genc, A., Genc, E. S., Cansiz, A., & Emul, M. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.110 · Cited by 105
“, 2013), and activated lymphocyte cell subsets (Breunis et al., 2003; Drexhage et al., 2011), have been observed in different stages of patients with BD.”
BackgroundBarbosa, I. G., Rocha, N. P., Assis, F., Vieira, E. L. M., Soares, J. C., Bauer, M. E., & Teixeira (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu021 · Cited by 101
Chemokine alterations in bipolar disorder: A systematic review and meta-analysis
Misiak, B., Bartoli, F., Carrà, G., Małecka, M., Samochowiec, J., Jarosz, K., Banik, A., & Stańczykiewicz, B. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.013 · Cited by 102
Brambilla, P., Bellani, M., Isola, M., Bergami, A., Marinelli, V, Dusi, N., Rambaldelli, G., Tansella, M., Maria Finardi, A., Martino, G., et al. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.46 · Cited by 86
Rizzo, L. B., Do Prado, C. H., Grassi-Oliveira, R., Wieck, A., Correa, B. L., Teixeira, A. L., & Bauer, M. E. (2013) · Bipolar Disorders · doi:10.1111/bdi.12121 · Cited by 73
Immune and Neuroimmune Alterations in Mood Disorders and Schizophrenia
Drexhage, R. C., Weigelt, K., van Beveren, N., Cohen, D., Versnel, M. A., Nolen, W. A., & Drexhage, H. A. (2011) · International Review of Neurobiology · doi:10.1016/b978-0-12-387718-5.00007-9 · Cited by 71
Self-citationInanli, I., Aydin, M., Çaliskan, A. M., & Eren, I. (2019) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2019.1640789 · Cited by 69
Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium
Sakrajda, K., & Szczepankiewicz, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041532 · Cited by 65
Wieck, A., Grassi-Oliveira, R., do Prado, C. H., Rizzo, L. B., de Oliveira, A. S., Kommers-Molina, J., Viola, T. W., Teixeira, A. L., & Bauer, M. E. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.07.005 · Cited by 63
Overlapping evidence of innate immune dysfunction in psychotic and affective disorders
Hughes, H. K., & Ashwood, P. (2020) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2020.100038 · Cited by 39
Neutrophil/lymphocyte and platelet/lymphocyte ratios in all mood states of bipolar disorder
Giynas Ayhan, M., Cicek, I. E., Inanli, I., Caliskan, A. M., Kirci Ercan, S., & Eren, I. (2017) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2017.1338822 · Cited by 26
Chou, Y.-H., Hsieh, W.-C., Chen, L.-C., Lirng, J.-F., & Wang, S.-J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.10.056 · Cited by 23
Clinical Phenotype of Depression Affects Interleukin-6 Synthesis
Zadka, Ł., Dzięgiel, P., Kulus, M., & Olajossy, M. (2017) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0074 · Cited by 20
Metadata
- Authors
- Drexhage, R. C., Hoogenboezem, T. H., Versnel, M. A., Berghout, A., Nolen, W. A., & Drexhage, H. A.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 25
- Issue
- 6
- Pages
- 1206-1213
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W1967211556
- Cited by
- 173
- References
- 5
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.